NZ didnt make any money in the first half, but if some kind of recovery there was priced into FY25 that might be a negative. Not sure of the consensus, but obviously redeploying capital to a higher return is better in the long run for the company, if it has been judged a recovery there is not worth sticking around for.
re: regulatory issues, those are going to cost, be sure of that. Already millions in legal fees.
Ann: Strategic Update, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.015(1.42%) |
Mkt cap ! $222.9M | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $943.8K | 870.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3810 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3429 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SVR (ASX) Chart |